The epicardium is essential for proper development of the heart and plays an important role in cardiac recovery during disease. Studies in model organisms have demonstrated that these effects are mediated either through the generation of epicardial-derived cell populations that participate in formation of the heart or through the secretion of paracrine factors by the epicardium that influence the development and proliferation of other cell types in the heart including cardiomyocytes. Given their pivotal role in normal development and disease, the epicardium and derivative cell types will have to be included as essential components of engineered heart tissue that is generated to assess drug responses and to model disease in vitro. Additionally, the ability of epicardial cells to regulate cardiomyocyte proliferation during development can be exploited to develop new strategies for replacing or regenerating functional myocardium for the treatment of cardiovascular disease. The generation of unlimited numbers of human pluripotent stem cell (hPSC)-derived epicardial cells through the approach described in this study provides an unprecedented opportunity to develop these applications.
In the adult epicardium, myocardial infarction leads to upregulation of these genes, cell proliferation and EMT, suggesting that the epicardium is involved in the remodeling process following infarct 15, 16 . Lineage-tracing studies have provided evidence that this activated epicardium generates new cardiomyocytes along with fibroblasts and vascular smooth muscle cells, indicating that it may contribute to the development of new myocardium [17] [18] [19] . However, the extent to which an epicardium-to-cardiomyocyte transition occurs is unclear.
Our understanding of epicardial lineage development and function is derived almost entirely from studies on model organisms, as access to fetal human heart tissue is limited. Studies with epicardium isolated from the adult human heart show that the cells rapidly undergo EMT in culture, preventing detailed studies on the epithelial cell population 20 . The generation of epicardium in vitro from hPSCs would overcome issues of accessibility and provide an unlimited source of human cells for functional studies in vitro and in experimental models in vivo. In this study, we have addressed this issue and demonstrate that the combination of BMP and WNT signaling promotes the generation of a WT1 + TBX18 + epicardial cell-like population at the expense of cardiomyocytes from PDGFRA + mesoderm. Following passage, these cells mature and form epithelial-like sheets with tight junctions as demonstrated by the expression of ZONA OCCULEDENS-1 (ZO1). Along with ZO1, the cells upregulate expression of ALDH1A2 and exhibit aldehyde dehydrogenase activity, an indication of their ability to synthesize retinoic acid. Finally, we show that when induced with TGFB1 and bFGF, the epicardial-like cells undergo EMT and give rise to cells that display characteristics of smooth muscle cells and fibroblasts.
RESULTS

BMP dose-dependently specifies the cardiomyocyte lineage
The differentiation of hPSCs toward the cardiomyocyte lineage progresses through three stages; (i) the induction of cardiovascular mesoderm defined by the expression of KDR and PDGFRA, (ii) the specification of the cardiovascular mesoderm to a cardiomyocyte fate and (iii) the maturation of the specified progenitors to functional cardiomyocytes (Fig. 1a) . Whereas NODAL/ACTIVINA and BMP4 are known to be key regulators in the generation of cardiac mesoderm during the first stage of differentiation, the pathways controlling the specification toward the cardiomyocyte lineage during the second stage are ill-defined 21 . To investigate the specification step, we established a protocol that enabled us to easily manipulate signaling pathways during this stage of development in human embryonic stem cell (hESC) differentiation cultures (Fig. 1a) . With this approach, KDR + PDGFRA + cardiovascular mesoderm is induced in embryoid bodies with optimal concentrations of ACTIVINA and BMP4 as previously described 21 . On day (D) 4 of differentiation, the embryoid bodies are dissociated, and the cells are plated as a monolayer for the specification stage and cultured in the presence of different signaling pathway agonists and antagonists for 48 h. The cultures are then maintained in media containing VEGF and analyzed at D15 for the presence of cardiac Troponin T (CTNT) + cardiomyocytes by flow cytometry.
As our previous studies have shown that cardiomyocytes develop from KDR + PDGFRA + mesoderm in the presence of the WNT inhibitor DKK1 and the ACTIVIN/NODAL/TGFB inhibitor SB-431542 (ref. 21) , these pathway antagonists were included in the culture during the specification step. Given that BMP signaling is required for Figure 1 BMP specifies the differentiation of cardiomyocytes from hESC-derived mesoderm. (a) Scheme of the protocol used to differentiate hESCs toward the cardiomyocyte lineage highlighting the three main stages of development: (1) mesoderm induction, (2) cardiovascular specification and (3) maturation. Cells from ACTIVINA/BMP4induced D4 embryoid bodies are plated as a monolayer on gelatin-coated wells. The BMP pathway was manipulated for a 48-h period (D4-D6) in the presence of VEGF (5 ng/ml), SB-431542 (SB; 5.4 µM) and DKK1 (150 ng/ml). Following specification, the cultures were maintained in VEGF (5 ng/ml) for 9 days and then analyzed for the presence of CTNT + cells by flow cytometry. A r t i c l e s cardiovascular development from mesoderm in the early embryo 22 , and can modulate cardiomyocyte development from hPSC-derived cardiac progenitor cells 21 , we focused our initial effort on further exploring the role of this pathway in the specification of the cardiovascular lineage. Manipulation of the pathway had a profound effect on cardiogenesis, as addition of BMP4 or the BMP-specific inhibitor NOGGIN during this 48-h window completely blocked cardiomyocyte development as shown by the lack of CTNT + cells at D15 (Fig. 1b) . The generation of KDR + PDGFRA + mesoderm at D5 of differentiation was not affected by these manipulations. The lack of cardiomyocyte development was not due to an increase in cell death as similar numbers of cells were detected in each group at D15 (Supplementary Fig. 1a ). To investigate the requirement for BMP signaling during the specification of cardiomyocytes, we carried out a titration of NOGGIN and BMP4 between D4 and D6 of differentiation. A clear dose dependency for BMP signaling was observed, with optimal cardiomyocyte specification occurring in cultures treated with levels of NOGGIN ranging from 12.5 to 50 ng/ml ( Fig. 1c ). Some interexperiment variation was observed with respect to the optimal NOGGIN concentrations required for the specification of cardiomyocytes and for blocking cardiogenesis. This variation typically coincided with lot changes in reagents (data not shown).
To define in more detail the temporal aspects of cardiomyocyte specification, we manipulated BMP signaling at different 12-h intervals between D4 and D6 of differentiation ( Fig. 1d ; top panel, intervals 1-10). The untreated control cultures underwent efficient cardiomyocyte specification, as indicated by the high proportion of CTNT + cells detected at D15. The inhibitory effects of BMP4 and NOGGIN were most pronounced when these factors were added between D4 and D5 of culture (groups 1-5, 8, 9) . If addition of the BMP agonist or antagonist was delayed to D5 or beyond, cardiomyocytes were detected in the resulting cultures (groups 6, 7 and 10). Addition of the agonist and antagonist for a 12-h period during the D4-5 time frame was sufficient to inhibit cardiomyocyte development (groups 4, 8 and 9). Taken together these findings demonstrate that an optimal concentration of BMP4 is required for cardiomyocyte specification at D4 of differentiation and that the duration of this BMP-dependent stage is ~24 h.
BMP4 treatment specifies a WT1 + epicardial population
The fact that cell numbers were not significantly influenced by the manipulation of the BMP pathway indicated that other cells types, possibly of other cardiovascular lineages, were generated in the presence or absence of BMP signaling. To begin to characterize these cell populations, we assessed gene expression patterns indicative of different cardiovascular cell types, as well as of other mesoderm-derived lineages, by quantitative real-time PCR (qRT-PCR) (Figs. 2a and data not shown). As expected, genes associated with cardiomyocyte development, including TNNT2 and the cardiac transcription factor NKX2-5, were expressed only in the untreated control cultures. Notably, two epicardial markers, WT1 and TBX18, were expressed exclusively (WT1) or predominantly (TBX18) in the cultures treated with BMP4, indicating that these cells may represent the developing epicardial lineage ( Fig. 2a) . Immunostaining confirmed the qRT-PCR findings and demonstrated that the BMP4-treated cells expressed nuclear WT1 protein ( Fig. 2b) . WT1 was not detected in the NOGGIN-treated or untreated cells, indicating that it was specifically upregulated in the BMP4-treated group. Immunostaining for CTNT was observed only in untreated cultures ( Fig. 2b) , confirming the qRT-PCR and FACS analyses.
In vivo, epicardial cells form an epithelial layer that surrounds the developing heart. In addition to their distinct cobblestone morphology, epithelial cells in culture are characterized by their ability to form tight junctions that can be monitored by the presence of ZO1 along the cell membrane 4 . At D15 of culture the WT1-expressing cultures did not display the cobblestone morphology typical of cultured epithelial cells and ZO1 expression was not readily observed along the cell borders ( Fig. 3a) . However, following passage and culture in a larger format (from a 96-well to a 6-well plate) for 4 d, WT1 + cells expanded to generate a confluent monolayer with a cobblestone morphology ( Fig. 3a) . These cells maintained expression of WT1 and now expressed ZO1 along well-defined cell borders. Given these characteristics, the D15, pre-passaged, WT1 + cells will be referred to as pro-epicardial (P-Epi) cells and the post-D15, passaged, WT1 + cells as epicardial (Epi) cells.
Molecular analyses revealed that the P-Epi cells expressed the cardiogenic genes GATA4, GATA5, ISL1 and TBX5 at levels similar to those found in the cardiomyocytes (Fig. 3b) . With passage, expression of npg ISL1 and GATA5 was downregulated. These patterns largely reflect those in the developing epicardium in the mouse [23] [24] [25] [26] . Through microarray analyses, Bochmann et al. 27 identified sets of genes that were expressed at significantly higher levels in the epicardium than in the myocardium of the adult mouse. We analyzed six genes from the set that showed a large expression differential in their study (BNC1, ANXA8, GPM6A, UPK1B, KRT8 and KRT19) and found that the expression of all were upregulated in the passaged Epi cells compared to the P-Epi cells and cardiomyocytes ( Fig. 3b) .
To further characterize the P-Epi and Epi cell populations, we analyzed them for the expression of various surface antigens by flow cytometry. The expression patterns of these populations were compared to that of D15 cardiomyocytes ( Supplementary Fig. 1b) . The cardiomyocytes and both Epi populations expressed podoplanin (PDPN), a transmembrane glycoprotein thought to be associated with cell migration and found on developing mouse cardiomyocytes and on adult mouse epicardium 27, 28 . Notably, both Epi populations were also positive for SIRPA, a receptor we have previously shown to be expressed on hPSC-derived and fetal cardiomyocytes 29 . The Epi populations, but not the cardiomyocytes, expressed the mesenchymal/ fibroblast marker CD90, although the levels appeared to decrease with passage. PDGFRB, expressed on embryonic epicardium in the mouse, was detected at low levels in both Epi populations 30 . In contrast, the mesoderm progenitor marker PDGFRA was not expressed on any of the populations, indicating that it is downregulated with lineage specification. None of the populations expressed CD31, VE-CADHERIN or CKIT (data not shown). Taken together with the above molecular analyses, these findings provide strong evidence that the hPSCderived Epi populations represent the human epicardial lineage.
To demonstrate that the WT1-expressing cells develop from the mesodermal population present at D4, we isolated the PDGFRA + (mesoderm) and PDGFRA − (non-mesoderm) fractions at this time point by FACS and cultured the cells either without further treatment or with BMP4 for 48 h (Supplementary Fig. 2a ). Cultures were maintained until D15 ( Fig. 1a) . Flow cytometry and immunostaining revealed that CTNT + cardiomyocytes (Supplementary Fig. 2b ) and WT1 + cells ( Supplementary Fig. 2c ) were generated only from the PDGFRA + population indicating that these cells types are of mesodermal origin. Gene expression analysis confirmed these findings and showed that that expression of WT1 and additionally TBX18 were detected only in the BMP4-treated PDGFRA + mesoderm-derived population (Supplementary Fig. 2d ).
WNT signaling co-regulates cardiac lineage specification
Our findings that BMP signaling can specify the cardiomyocyte and P-Epi lineages in the presence of WNT and ACTIVIN/NODAL/TGFB inhibitors suggest that these pathways do not play a role at this stage of epicardial development. This interpretation is not, however, in line with the observations that the hearts of Dkk1 −/− Dkk2 −/− null mice have an increased thickness of the epicardium and a thinner myocardium compared to wild-type littermates. These findings suggest that Wnt 31 . To reconcile these differences, we further manipulated WNT signaling at this stage, specifically focusing on inhibition of the pathway by addition of increased amounts of DKK1, or the smallmolecule antagonists XAV939 (XAV) and IWP2. These antagonists were added to cultures containing either BMP4 (10 ng/ml), the smallmolecule BMP inhibitor dorsomorphin 32 (4 µM; in place of NOGGIN) or no other factors (endogenous BMP). Increasing the concentration of DKK1 in the presence of BMP4 promoted the development of cardiomyocytes at the expense of P-Epi cells as indicated by the lack of WT1 expression in the population treated with 1,200 ng/ml of the antagonist (Fig. 4a,b ). The addition of XAV or IWP2 had similar effects to that of high concentrations of DKK1 ( Fig. 4c,d) . The cardiomyocyte potential of the dorsomorphin-treated and nontreated cultures were largely unaffected by these manipulations (Fig. 4a,c,d) . As expected, activation of the canonical WNT pathway by the addition of the small-molecule WNT agonist CHIR99021 (CHIR) inhibited cardiomyocyte development in the endogenous BMP control (Fig. 4a) . Western blot analyses showed that the untreated population (endogenous BMP) contained pSMAD1/5/8 that was inhibited by the addition of dorsomorphin, consistent with the interpretation that the BMP pathway was active in the cells in the absence of added ligand (Supplementary Fig. 3a) .
The levels of pSMAD1/5/8 were not appreciably affected by the addition of a WNT inhibitor indicating that manipulation of the WNT pathway does not impact BMP/pSMAD signaling. qRT-PCR analyses revealed that the addition of BMP4 did not significantly increase the level of expression of the WNT/BETA-CATENIN target AXIN2 above that in the untreated population, suggesting that the BMP4 pathway does not directly regulate canonical WNT signaling ( Fig. 4e) . Addition of IWP2, XAV or high (1,200 ng/ml) but not low (150 ng/ml) concentrations of DKK1 led to a significant reduction in AXIN2 expression, consistent with the observation that these manipulations promoted cardiac development.
The addition of high concentrations of DKK1 (600 ng/ml and above) or the small-molecule antagonists XAV and IWP2 decreased WT1 expression in BMP4-treated cells indicating a loss of P-Epi cells with specification of the cardiomyocyte lineage ( Fig. 4b-d) .
Activation of the WNT pathway by CHIR did not affect WT1 expression in BMP4-treated cells but did result in increased expression in the endogenous BMP population. Dorsomorphin-treated cultures showed no change in WT1 expression following these manipulations (Fig. 4b) . Taken together, these observations demonstrate that BMP signaling is required for specification of both the cardiomyocyte and Epi lineages as neither develops in the dorsomorphin-treated cultures. In the context of BMP signaling, development of the Epi lineage is dependent on WNT signaling, whereas establishment of the cardiomyocyte lineage requires efficient inhibition of this pathway.
Studies in the chick embryo have provided evidence that bFGF signaling promotes proliferation and mesenchymal differentiation of the proepicardial organ cells in tissue explant cultures 33 , suggesting that this pathway may play a role in the early stages of Epi lineage development. To determine whether FGF affects P-Epi specification from hPSCs, we manipulated the pathway by the addition of bFGF or the FGF receptor antagonist PD-173074 together with BMP4 and CHIR to D4 mesoderm. Addition of PD-173074 did not affect WT1 expression or cell number output compared to the nontreated control ( Supplementary Fig. 3b) . Conversely, the addition of bFGF inhibited WT1 expression indicating that signaling through this pathway is Fig. 3b ). Cell numbers were not affected by the addition of bFGF, suggesting that signaling through this pathway promoted the development of an alternative cell lineage. Based on the inclusion of VEGF during culture, we wanted to determine whether this signaling pathway affects epicardial lineage specification and maturation. Notably, the D15 P-Epi population expressed KDR (Supplementary Fig. 3c ), suggesting that this population may respond to VEGF signaling. Removal of VEGF from the specification step or during the following 9 d of culture had no detrimental effect on D15 KDR expression, WT1 expression or total cell output, indicating that it is not required for establishment of the lineage (Supplementary Fig. 3c,d) . The majority of passaged Epi cells maintained expression of KDR, however, addition of VEGF during the culture of the Epi population resulted in a reduction in the number cells generated 8 d later (Supplementary Fig. 3e,f) . The reduction in cell number was not associated with maturation along the endothelial lineage, however, as the cells did not upregulate CD31 (Supplementary Fig. 3e ).
Given the above findings, for the remaining experiments in this study cardiomyocytes were generated by the addition of BMP4 and XAV or IWP2 to D4 mesoderm whereas the combination of BMP4 and CHIR was used to induce the Epi lineage. Cells treated with the BMP inhibitor dorsomorphin were used as the noncardiomyocyte, non-Epi, control population. With this approach it was possible to generate Epi cells from other hPSC lines, including a human, fibroblast-derived, induced PSC line (Sendai hiPSC) and the hESC line H7 (Supplementary Fig. 4a,b) . The protocol used for Epi development from the HES2 hESCs was also used for the second hESC line H7. For the Sendai hiPSC line we shortened the mesoderm induction stage by 1 d (D1-3), as we have previously shown that the kinetics of differentiation is accelerated in some iPSCs 21 .
hPSC-derived epicardial cells undergo EMT
Previous studies have shown that both mouse and chick embryonic epicardial cells undergo EMT in vitro in response to factors that regulate this process in vivo including TGFβ1 (refs. 4,5), Wnt 6 , RA 6 , FGF 7 , PDGF 8 and give rise to cell populations that display properties of the fibroblast and vascular smooth muscle lineages. To determine whether the hESC-derived Epi cells can undergo EMT, we designed an assay in which D15 P-Epi cells are passaged, allowed 1 d to recover, and then treated for a total of 8 d with one of four treatment regimens. The regimens consisted of: (i) TGFB1 for 4 d followed by 4 d with no additional factor (TGFB), (ii) bFGF for 8 d (bFGF), (iii) TGFB1 for 4 d followed by 4 d with bFGF (TGFB + bFGF) or (iv) no additional factors for 8 d (Fig. 5a) . Following culture under the different conditions, the cells were harvested and analyzed by qRT-PCR, flow cytometry and immunostaining.
Maintaining cultures in the absence of factors or in the presence of bFGF led to a doubling of cell numbers over the 8-d period (Fig.  5b) . In contrast, cell numbers in cultures treated with TGFB alone or TGFB + bFGF remained at input or lower than input levels. Expression levels of WT1 in the control cells were downregulated immediately after passage and then gradually upregulated over the 8-d culture period (Fig. 5c) . Cells treated with either TGFB or TGFB + bFGF showed steady decreases in WT1 expression over time, indicating the transition toward an EPDC phenotype (Fig. 5b,c) . In contrast, the levels of WT1 expression did not decline below those of the control in the bFGF-treated cells. Expression of the EMT markers SNAI1 and SNAI2 also increased in the treated populations, although the levels npg A r t i c l e s varied depending on the cytokine combination. TGFB, TGFB + bFGF and bFGF all led to increases in SNAI2 expression, whereas only bFGF induced the expression of SNAI1 (Fig. 5c) . The recent findings by Casanova et al. 34 demonstrating that SNAI1 is dispensable for epicardial EMT may explain why its expression levels did not change in the TGFB-treated cultures. Immunostaining illustrated that ZO1 was lost from cell borders and possibly internalized following TGFB or bFGF treatment (Fig. 5d) . Expression of WT1 seen by immunostaining was consistent with transcript expression determined by qRT-PCR. The most significant change in WT1 and ZO1 staining was observed in TGFB + bFGB-treated cells, although they were largely morphologically indistinguishable from those treated with only TGFB. Flow cytometry showed that cells in all groups had upregulated the mesenchymal marker CD90 compared to the untreated control ( Fig. 5e) , supporting the interpretation that TGFB and bFGF had initiated EMT. Taken together, these findings indicate that the Epi cells were capable of undergoing EMT following activation of the TGFB and bFGF pathways and provide further evidence that they represent the in vitro equivalent of the developing epicardium. To identify the cell types being induced by EMT, the derivative populations were analyzed by immunostaining for the presence of the mesenchymal marker VIMENTIN (VIM) and the smooth muscle marker ALPHA-SMOOTH MUSCLE ACTIN (ASMA) and by qRT-PCR for expression of the smooth muscle genes CNN1, MYH11, TAGLN and SMTN 35 and the epicardium-derived fibroblast marker TCF21 (ref. 36) . Although VIM was expressed to some degree in all populations, substantially higher levels were observed in cells induced by TGFB and TGFB + bFGF than in those cultured with bFGF alone (Fig. 6a) . ASMA was also detected at higher levels in the TGFB-and TGFB + bFGF-induced cells compared to those induced with bFGF or those cultured in the absence of factors. These patterns suggest that cells induced with either TGFB or TGFB + bFGF are progressing along the vascular smooth muscle lineage (Fig. 6a) . In support of this is the observation that expression of CNN1, MYH11, TAGLN and SMTN but not of TCF21 was upregulated in these cells (Fig. 6b) . In contrast, the bFGF-induced population expressed TCF21 in addition to CNN1, TAGLN and SMTN. These cells did not express substantial levels of MYH11 (Fig. 6b) . Collectively, these findings indicate that TGFB specifies the Epi cells toward a smooth muscle-like fate whereas bFGF promotes the development of fibroblast-like cells. bFGF treatment following TGFB treatment appeared to enhance the smooth muscle-like fate as observed by the increased expression of CNN1, MYH11, TAGLN and SMTN in these cells.
To test the contractile function of the smooth muscle-like cells generated following the EMT induced with TGFB and TGFB + bFGF, we measured calcium transients following stimulation with norepinephrine (NE) and phenylephrine (PE) using previously described methods 37 (Supplementary Fig. 5a,b and Supplementary Video 1) . The proportion of cells displaying calcium transients was highest (70%) in the population induced by TGFB + bFGF indicating, that this combination of signaling pathways efficiently promoted the development of smooth muscle cells capable of contraction ( Fig. 7a) . Of the cells that exhibited calcium transients, similar rates of cycling were observed in the cells induced by TGFB and TGFB + bFGF following PE stimulation. Cells from both populations exhibited faster calcium cycling rates than those in the noninduced control cultures (Supplementary Fig. 5c ). The amplitude of calcium response was greatest in phenylephrine-treated TGFB cells compared to control npg cultures (Supplementary Fig. 5d ). Finally, the duration of calcium transients following phenylephrine-treatment was longer in the TGFB + bFGF-induced cells than in those treated with TGFB or those in the control population (Supplementary Fig. 5e ). Taken together these findings demonstrate that induction of the Epi cells with the combination of TGFB + bFGF promotes the development of smooth muscle cells capable of responding to agonists that result in increased calcium handling.
It is well-established that during heart development EPDCs, and in particular cardiac fibroblasts, invade the myocardial layer 9 . To assess this potential of the hPSC-derived Epi cells, we measured their ability to invade a three-dimensional (3D) layer of Matrigel following induction of EMT with the different factors. To enable us to easily track the migration of the cells, we generated the Epi population from GFP-expressing hESCs 38 . Matrigel invasion was monitored 8 d following the induction of EMT by confocal microscopy and evaluated using 3D image reconstruction ( Supplementary Fig. 6a and a′) . The cells induced with bFGF alone were the most migratory and invaded the Matrigel to the greatest depth ( Fig. 7b) , supporting the interpretation that they are fibroblastic in nature. Along with invasion, bFGF treatment also led to an increase in total cell number within the regions of interest (ROI). None of the other groups showed this expansion (no treatment, 73.8 ± 6.1 cells per ROI; TGFB, 56.8 ± 9.5 cells per ROI; bFGF, 379.7 ± 40.5 cells per ROI, P = 0.0017; TGFB + bFGF, 80.3 ± 17.1 cells per ROI). Notably, the population induced with TGFB alone showed little capacity to invade the Matrigel, even less than the nontreated control that may contain some cells that have undergone spontaneous EMT to the fibroblast lineage ( Supplementary Fig. 6a ; white arrow heads). Cells induced with the combination of TGFB + bFGF behaved similarly to the control population and were considerably less invasive than those induced with bFGF alone. To further quantify the degree of invasion, we calculated the proportion of cells in each population that migrated to different depths. Virtually all of the cells in the noninduced, the TGFB-induced and TGFB + bFGF-induced populations were detected within the first 200 µm of the gel (Supplementary Fig. 6b) . In contrast, approximately half of the cells in the bFGF-induced population migrated beyond this depth, some as far as 600 µm. Collectively, these findings demonstrate that the bFGF-induced population displays migratory behavior consistent with that predicted for EPDCs in vivo. The observation that the cells with smooth muscle characteristics do not show this potential suggests that the maturation of this lineage likely occurs following migration into the tissue.
hESC-derived epicardium has aldehyde dehydrogenase activity It is well accepted that the epicardium produces retinoic acid during development and after cardiac injury through the upregulation of ALDH1A2. At D15 of differentiation P-Epi cells did not express ALDH1A2 (Supplementary Fig. 7a ), nor did they stain positive for Aldefluor by flow cytometry, a marker of aldehyde dehydrogenase activity (Supplementary Fig. 7b ). Following passage, however, this population showed steady increases in ALDH1A2 expression ( Supplementary Fig. 7c) . The retinaldehyde dehydrogenases 1 and 3 (ALDH1A1 and ALDH1A3), also involved in the synthesis of retinoic acid but not associated with the epicardium, were expressed at lower levels than ALDH1A2 ( Supplementary  Fig. 7a ). Eight days following passage, the Epi cell population had substantially upregulated aldehyde dehydrogenase activity as measured by Aldefluor staining to the stage at which >75% were positive (Supplementary Fig. 7d ). Cultures in which EMT had been induced with TGFB, bFGF or TGFB + bFGF showed dramatically lower levels of ALDH1A2 expression and Aldefluor staining, consistent with the interpretation that they have lost their Epi identity.
Taken together, our results show that the stage-specific activation of BMP4 and WNT signaling regulates the specification of P-Epi cells from hPSC-derived mesoderm. Once passaged, Epi cells have the ability to undergo EMT toward smooth muscle-like and fibroblast-like cells in response to TGFB and bFGF. In the absence of an EMT-inducing signal, Epi cells acquired a cobblestone morphology and aldehyde dehydrogenase activity through the upregulation of ALDH1A2, indicating their ability to synthesize retinoic acid (Fig. 7c) . Based on immunostaining, we estimate that more than 85% (87.3% ± 7.1% N = 4, s.d. of the mean) of the P-Epi population is WT1 + on D15. The frequency of WT1 + cells increased to > 90% (94.3 ± 5.3%; N = 3, s.d. of the mean) 8 d following passage (D16 8). Given that we observe a fivefold increase in cell numbers between D4 and D16 + 8, we estimate an output of four to five Epi cells per D4 mesoderm input cell.
DISCUSSION
This study demonstrates the efficient and reproducible differentiation of hPSCs to epicardial-like cells that display many properties of the epicardium in other species, including the ability to undergo EMT to give rise to fibroblastic and vascular smooth muscle cell types. npg A r t i c l e s Our approach will enable future studies aimed at establishing the role of epicardial cells in cardiomyocyte growth and differentiation in vitro and in repair after cardiac injury in vivo. Access to stage-specific progenitors has enabled us to identify the BMP and canonical WNT pathways as key regulators of cardiomyocyte and epicardial specification from cardiogenic mesoderm (Fig. 7c) . Our findings show an absolute requirement for BMP signaling for the generation of both lineages as neither develops when the pathway is inhibited. In the presence of BMP signaling, the decision to differentiate toward the cardiomyocyte or epicardial lineages is mediated by the canonical WNT pathway. The cardiomyocyte fate is specified in the absence of WNT signaling, whereas the epicardial lineage is generated by activation of the WNT pathway. Our data also suggest that these pathways act independently, as the levels of pSMAD1/5/8 were not affected by inhibition of WNT, and AXIN2 expression did not increase following the addition of BMP4. One interpretation of these findings is that these pathways act sequentially, with BMP inducing a WNT-responsive population that displays both epicardial and cardiomyocyte potential. Whether or not these pathways do indeed act sequentially remains to be determined. In contrast to the BMP and WNT pathways, bFGF and NODAL/ ACTIVIN signaling do not play a role in epicardial specification, as the lineage can be initiated in the presence of antagonists of both pathways. In fact, FGF signaling between D4 and D6 of differentiation does not appear to be compatible with epicardial specification as addition of bFGF at this stage blocked development of the lineage. Kruithof et al. 33 have provided evidence that bFGF signaling promotes proliferation and mesenchymal differentiation of proepicardial organ cells in chick tissue explant cultures. These findings are not necessarily contradictory to ours, as the stage of development assayed in their study is likely most similar to the D15 P-Epi cells that we identified, a stage considerably later than the D4 mesoderm. In this regard, their observation that bFGF promotes mesenchymal differentiation is consistent with our findings that signaling through this pathway induces EMT in the hESC-derived Epi cells.
A pivotal role for BMP signaling in cardiac specification shown here is consistent with findings from studies in the mouse that demonstrate a block in heart development following the conditional knockout of Bmpr1a in cells expressing Mesp1-cre 22 . Additionally, the observation that inhibition of WNT signaling is required for specification of the cardiomyocyte lineage is in line with a large number of studies showing that stage-specific inhibition of the pathway is required for cardiogenesis in vivo and in hPSC differentiation cultures [39] [40] [41] . A specific requirement for this pathway in the specification of epicardial fate is supported by in vivo studies showing that the hearts of mice lacking the Wnt inhibitors Dkk1 and Dkk2 have a thicker epicardium and thinner myocardium compared to wild-type littermates. The efficient generation of epicardial lineage cells, even in the presence of endogenous levels of WNT signaling or suboptimal concentrations of DKK1 shown here, provides an explanation for the strict stage-specific requirement for inhibiting this pathway for generating cardiomyocytes and suggests that under suboptimal conditions cultures may be contaminated with epicardial cells or EPDCs.
Similar to the epicardium in vivo, the hPSC-derived epicardial cells can undergo EMT in vitro and give rise to cells that display characteristics of fibroblasts and vascular smooth muscle cells. Cardiac fibroblasts are necessary for proper cardiomyocyte alignment 42 , electrical propagation 43 and extracellular matrix deposition 42 . They are also one of the primary cell types involved during cardiac remodeling following injury 16 . Given the function of these cells in vivo, it is likely that they will play an important role in the development of engineered heart tissue constructs designed to create functional myocardium in vitro. In addition, as the epicardium is the primary source of coronary vascular smooth muscle cells, it is possible that the smooth muscle-like cells generated from the hESC-derived epicardial cells do represent this population. Access to these cells from epicardial progenitors could have clinical implications as alterations in the function of the vascular smooth muscle population is thought to be important in the development of atherosclerotic plaques 44, 45 . The generation of patient-specific smooth muscle cells through this approach will provide a model system to study the early changes associated with atherosclerosis and cardiovascular disease.
In summary, the findings presented here identify critical signaling pathways that regulate the specification of the cardiomyocyte and epicardial lineages from hPSC-derived mesoderm. With these insights, it is now possible to efficiently generate epicardial lineage cells from hPSCs, enabling us to define, in detail, their role in cardiac development, proliferation and maturation in vitro. Additionally, it will now be possible to investigate their function following transplantation into experimental animals in vivo, similar to the strategy used to test the effect of adult heart-derived EPDCs 46, 47 .
METHODS
Methods and any associated references are available in the online version of the paper.
